Clinical Trial Update: Feasibility Study of a Dose Increase by a Boost of Curietherapy in Pulse Dose Rate (PDR) Associated With the Extern Radiotherapy in Prostate Cancer [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov update reports the termination of a Phase 2 feasibility study evaluating a dose increase using a Curietherapy boost with external radiot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Prostate Cancer With Intermediate Risk | Phase 2 | Status: TERMINATED